Semaglutide Weight Loss in Gainesville, FL

How Semaglutide Works — GLP-1 Receptor Agonist Mechanism

Semaglutide is a GLP-1 receptor agonist — a synthetic peptide that mimics glucagon-like peptide 1, a hormone that regulates blood sugar and appetite. When you inject semaglutide, it activates GLP-1 receptors in your brain, signaling fullness and reducing hunger. Simultaneously, it slows gastric emptying, extending the feeling of satiety after meals.

The result: dramatically reduced appetite without willpower or restrictive dieting. Patients on semaglutide naturally eat 300–500 fewer calories per day because they feel fuller longer. Combined with light exercise and balanced nutrition, this creates a sustained calorie deficit — the foundation of healthy weight loss.

At Bespoke Aesthetics, Dr. Indianos prescribes semaglutide (Ozempic equivalent) and monitors your response via baseline labs, injection training, dose escalation protocols, and ongoing telemedicine plus in-person follow-ups. Your dosing is personalized to your metabolism — not the standard dose most apps use.

Semaglutide Results — What to Expect, Week by Week

Weeks 1–2: initial dose (0.25 mg weekly); mild appetite suppression; possible mild nausea (subsides in 1–2 weeks with dietary adjustment).

Weeks 2–4: weight loss becomes noticeable (2–4 lbs); nausea typically resolves; increased fullness sensation with smaller meals.

Weeks 4–8: dose escalation (0.5 mg → 1 mg weekly); accelerated weight loss; energy increases as metabolism stabilizes.

Weeks 8–12: maintenance dose achieved (1–1.2 mg weekly); sustained weight loss (8–20 lbs total typical by 12 weeks); appetite remains suppressed; comfortable eating smaller, nutrient-dense portions.

Months 3–6: continued gradual weight loss; total body weight reduction of 15–30 lbs typical with adherence and dietary support.

Ongoing maintenance: once goal weight is reached, transition to maintenance dose (0.5–1 mg weekly) with quarterly check-ins. Maintenance requires continued medication use; discontinuation typically results in appetite return.

These are typical results with medical supervision; individual variation is normal. Dr. Indianos discusses realistic expectations for your specific baseline and health history.

Semaglutide Side Effects — Management Strategies

Most common side effects are gastrointestinal: nausea (40–50% of patients), vomiting, constipation, diarrhea. These are typically mild-to-moderate and subside within 2–3 weeks as your body adjusts.

Nausea management: eat smaller, more frequent meals; avoid fatty or spicy foods; increase hydration; consider ginger supplements or anti-nausea medication (prescription available).

Constipation: increase fiber intake gradually, drink 80+ oz water daily, consider magnesium supplement, light daily exercise.

Diarrhea: reduce fiber temporarily, eat bland foods (rice, chicken, toast), avoid artificial sweeteners.

Serious side effects (rare with physician supervision): pancreatitis (abdominal pain), thyroid concerns (family history of thyroid cancer is a contraindication), gallbladder issues. Dr. Indianos screens for contraindications during your baseline consultation.

Semaglutide vs. Tirzepatide — Which Is Right for You?

Both medications are FDA-approved for weight loss. The key difference is mechanism of action.

Semaglutide (GLP-1 agonist): 10–20% body weight loss over 12 weeks; single hormone mechanism (appetite suppression); longer market history; good for straightforward weight loss and mild metabolic dysfunction.

Tirzepatide (GIP/GLP-1 agonist): 20–25% body weight loss over 12 weeks; dual hormone mechanism (appetite plus glucose regulation); newer; particularly effective for insulin resistance, PCOS, and metabolic dysfunction.

Dr. Indianos reviews your baseline labs (fasting insulin, glucose, A1C, lipid panel) and health history to recommend the medication best suited to your individual metabolism. Many patients start with semaglutide and escalate to tirzepatide if results plateau.